205 related articles for article (PubMed ID: 30465494)
1. Progresses in microRNA Delivery Using Synthetic Nanovectors in Cancer Therapy.
Javanmardi S; Aghamaali MR; Abolmaali SS; Tamaddon AM
Curr Pharm Des; 2018; 24(31):3678-3696. PubMed ID: 30465494
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale delivery systems for microRNAs in cancer therapy.
Boca S; Gulei D; Zimta AA; Onaciu A; Magdo L; Tigu AB; Ionescu C; Irimie A; Buiga R; Berindan-Neagoe I
Cell Mol Life Sci; 2020 Mar; 77(6):1059-1086. PubMed ID: 31637450
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
5. Micromanipulating cancer: microRNA-based therapeutics?
Petrocca F; Lieberman J
RNA Biol; 2009; 6(3):335-40. PubMed ID: 19535911
[TBL] [Abstract][Full Text] [Related]
6. CD44 Targeted Lipid Nanoparticles for MicroRNA Therapy.
Hayward SL; Kidambi S
Methods Mol Biol; 2018; 1831():95-109. PubMed ID: 30051427
[TBL] [Abstract][Full Text] [Related]
7. miRNA nanotherapeutics for cancer.
Ganju A; Khan S; Hafeez BB; Behrman SW; Yallapu MM; Chauhan SC; Jaggi M
Drug Discov Today; 2017 Feb; 22(2):424-432. PubMed ID: 27815139
[TBL] [Abstract][Full Text] [Related]
8. Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics.
Tyagi N; Arora S; Deshmukh SK; Singh S; Marimuthu S; Singh AP
J Biomed Nanotechnol; 2016 Jan; 12(1):28-42. PubMed ID: 27301170
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-based therapeutics for cancer.
Wang V; Wu W
BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.
Awasthi R; Rathbone MJ; Hansbro PM; Bebawy M; Dua K
Drug Deliv Transl Res; 2018 Feb; 8(1):97-110. PubMed ID: 29185148
[TBL] [Abstract][Full Text] [Related]
11. Nucleic acid nanotechnology for cancer treatment.
Jin JO; Kim G; Hwang J; Han KH; Kwak M; Lee PCW
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188377. PubMed ID: 32418899
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and cancer therapeutics.
Yeung ML; Jeang KT
Pharm Res; 2011 Dec; 28(12):3043-9. PubMed ID: 21773853
[TBL] [Abstract][Full Text] [Related]
13. Non-viral based miR delivery and recent developments.
Labatut AE; Mattheolabakis G
Eur J Pharm Biopharm; 2018 Jul; 128():82-90. PubMed ID: 29679644
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic microRNA Delivery Strategies with Special Emphasis on Cancer Therapy and Tumorigenesis: Current Trends and Future Challenges.
Chakraborty C; Wen ZH; Agoramoorthy G; Lin CS
Curr Drug Metab; 2016; 17(5):469-77. PubMed ID: 26813887
[TBL] [Abstract][Full Text] [Related]
16. Polyethylenimines for siRNA and miRNA delivery in vivo.
Höbel S; Aigner A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy.
O'Neill CP; Dwyer RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32102476
[TBL] [Abstract][Full Text] [Related]
18. Lipid Nanoparticles to Deliver miRNA in Cancer.
Campani V; De Rosa G; Misso G; Zarone MR; Grimaldi A
Curr Pharm Biotechnol; 2016; 17(8):741-9. PubMed ID: 27215371
[TBL] [Abstract][Full Text] [Related]
19. Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.
Bai Z; Wei J; Yu C; Han X; Qin X; Zhang C; Liao W; Li L; Huang W
J Mater Chem B; 2019 Feb; 7(8):1209-1225. PubMed ID: 32255160
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy.
Hu YL; Fu YH; Tabata Y; Gao JQ
J Control Release; 2010 Oct; 147(2):154-62. PubMed ID: 20493219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
